Statistics:

• Independent/Not-for-profit [501(c)(3)] • 650-1000 research projects • ~100 Investigators - MDs & PhDs

– 75% are LA County Employees (Harbor-UCLA)

• 950+ employees (700 on campus)

Missions:

Biomedical Research Training and Education Community Service

Relationships

Clinical Care Teaching Research

Academic Medical Center

Relationships

Clinical Care Teaching Research

Harbor-UCLA Medical Center UCLA School of Medicine

LA BioMed

LA BioMed Paradigm What we see in the clinic is what we study in the lab.

Our discoveries are rapidly and efficiently protected and developed commercially

By doing so, LA BioMed IP arrives in the clinic in less time.

LA BioMed Highlights 1960’s-Present Paramedic Training Program Nurse-Practitioner Training Program Serum Cholesterol Test Tay-Sachs Blood Test 170,00 Live Births through Ovum Transfer Synthetic Lung Surfactants Anti-microbial eye drops COPD Rehab Therapy Vaccines against Hospital-acquired Infections Treatment for Sickle Cell Disease Male Birth Control Gel Melanoma Vaccine

On the Cutting Edge…

Licensing of LA BioMed IP

2007 2005

2004 2001

2011: PulSentry ImmunoTx 2012: BioAIM SyneuRx

Submental Fat

Treatment For Submental Fat

Michael Kolodney Now in Phase III Clinical Trials

IPO October 2012

Sickle Cell Disease

Red Blood Cells

Yutaka Niihara

Novel Inexpensive Therapy for Sickle Cell Disease

In Phase III Clinical Trials

Nosocomial = Hospital Acquired

Staphylococcus aureus

Candida albicans 60% Lethality

Infections

6th Leading Cause of Death

1. More invasive procedures 2. Antibiotic Resistance 3. No ROI

Vaccines against Nosocomial Infections

Jack Edwards

Phase II Clinical Trials Starting Soon

Christina Wang, MD

LA BioMed Paradigm What we see in the clinic is what we study in the lab.

Our discoveries are rapidly and efficiently protected and developed commercially

By doing so, LA BioMed IP arrives in the clinic in less time.